DCTH

11.34

2.49% -0.29

Dopo l'orario di chiusura: 11.63 0.29 +2.56%

Delcath Systems Inc (DCTH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$11.63

Aprire:

$11.51

Volume 24 ore:

308.24K

Relative Volume:

0.70

Capitalizzazione di mercato:

$387.48M

Reddito:

$2.07M

Utile/perdita netta:

$-47.68M

Rapporto P/E:

-4.0213

EPS:

-2.82

Flusso di cassa netto:

$-31.31M

1 W Prestazione:

-2.16%

1M Prestazione:

-17.35%

6M Prestazione:

+2.62%

1 anno Prestazione:

+132.85%

Intervallo 1D:

$11.04

$11.57

Intervallo di 1 settimana:

$11.04

$11.84

Portata 52W:

$4.87

$16.97

Delcath Systems Inc Stock (DCTH) Company Profile

Nome

Delcath Systems Inc

Settore

Healthcare (1182)

Industria

Medical Devices (159)

Telefono

(518) 743-8892

Indirizzo

566 QUEENSBURY AVENUE, QUEENSBURY, NY

Dipendente

Cinguettio

@delcathsystems

Prossima data di guadagno

2024-11-08

Ultimi documenti SEC

DCTH's Discussions on Twitter

Confronta DCTH con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DCTH Delcath Systems Inc	11.34	387.48M	2.07M	-47.68M	-31.31M	-2.82
ABT Abbott Laboratories	129.89	221.92B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	93.58	139.43B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	339.59	134.90B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	81.80	105.92B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	69.20	40.93B	5.72B	4.17B	259.90M	6.97

Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-06-28	Iniziato	Craig Hallum	Buy
2024-05-14	Iniziato	Stephens	Overweight
2022-07-26	Ripresa	Canaccord Genuity	Buy
2021-12-10	Iniziato	H.C. Wainwright	Buy
2021-03-09	Iniziato	Canaccord Genuity	Buy
2021-01-05	Iniziato	BTIG Research	Buy
2020-06-01	Iniziato	Laidlaw	Buy

Mostra tutto

Delcath Systems Inc Borsa (DCTH) Ultime notizie

Apr 20, 2025

(DCTH) Proactive Strategies - news.stocktradersdaily.com

Apr 20, 2025

Apr 10, 2025

Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock? - Nasdaq

Apr 10, 2025

Apr 09, 2025

Delcath Systems Announces Publication of Comparative Analysis fr - GuruFocus

Apr 09, 2025

Clinical Data: Delcath's Melanoma Treatment Achieves 175% Better Survival Than Standard Care - Stock Titan

Apr 09, 2025

Apr 04, 2025

How To Trade (DCTH) - news.stocktradersdaily.com

Apr 04, 2025

Apr 03, 2025

Pheochromocytoma Treatment Market Size in 7MM is expected - openPR.com

Apr 03, 2025

Apr 02, 2025

Hospitals Experience FOMO In Adopting Delcath’s PHP Treatment (NASDAQ:DCTH) - Seeking Alpha

Apr 02, 2025

Delcath Systems, Inc. (NASDAQ:DCTH) Is Expected To Breakeven In The Near Future - simplywall.st

Apr 02, 2025

Charles Schwab Investment Management Inc. Invests $156,000 in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World

Apr 02, 2025

5,470 Shares in Delcath Systems, Inc. (NASDAQ:DCTH) Acquired by Quantbot Technologies LP - Defense World

Apr 02, 2025

Apr 01, 2025

Delcath Systems (NASDAQ:DCTH) and West Pharmaceutical Services (NYSE:WST) Critical Survey - Defense World

Apr 01, 2025

Mar 28, 2025

Beta Bionics Announces Board Appointment of Gerard Michel - The Manila Times

Mar 28, 2025

Mar 27, 2025

Beta Bionics appoints new board member from Delcath Systems By Investing.com - Investing.com South Africa

Mar 27, 2025

Beta Bionics appoints new board member from Delcath Systems - Investing.com India

Mar 27, 2025

Jim Cramer Blesses Delcath Systems (DCTH): ‘You’re Not Early, But It’s a Win’ - MSN

Mar 27, 2025

Mar 26, 2025

Jim Cramer Discussed These 6 Stocks Recently - Insider Monkey

Mar 26, 2025

Wall Street Analysts See a 58.49% Upside in Delcath Systems (DCTH): Can the Stock Really Move This High? - MSN

Mar 26, 2025

Mar 24, 2025

Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference - Lelezard

Mar 24, 2025

Liver Cancer Treatment Breakthrough? Delcath to Reveal Latest Advances at Major Oncology Conference - Stock Titan

Mar 24, 2025

Mar 19, 2025

Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year? - Nasdaq

Mar 19, 2025

Mar 16, 2025

Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2024 Earnings Call Transcript - MSN

Mar 16, 2025

Mar 14, 2025

Delcath Systems awards stock options to new employees By Investing.com - Investing.com Australia

Mar 14, 2025

Delcath Systems awards stock options to new employees - Investing.com India

Mar 14, 2025

Delcath Systems Strengthens Workforce: 264,000 Stock Options Granted to New Strategic Hires - StockTitan

Mar 14, 2025

Mar 13, 2025

Delcath Systems Reports Strong 2024 Financial Growth - TipRanks

Mar 13, 2025

Mar 11, 2025

With A 27% Price Drop For Delcath Systems, Inc. (NASDAQ:DCTH) You'll Still Get What You Pay For - Simply Wall St

Mar 11, 2025

Mar 10, 2025

Delcath Systems’ Earnings Call Highlights Strong Growth and Strategic Expansion - TipRanks

Mar 10, 2025

Earnings Beat: Delcath Systems, Inc. (NASDAQ:DCTH) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance

Mar 08, 2025

Private Advisor Group LLC Acquires New Position in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World

Mar 08, 2025

Mar 07, 2025

Positive Outlook for Delcath Systems: Promising Growth and Strategic Expansion Drive Buy Rating - TipRanks

Mar 07, 2025

Delcath stock price target raised to $24 by H.C. Wainwright - Investing.com India

Mar 07, 2025

Strong Growth Potential for Delcath Systems: Buy Rating Affirmed with Raised Price Target - TipRanks

Mar 07, 2025

Delcath Systems reports net loss of USD 3.4M in Q4 2024 - Medical Buyer

Mar 07, 2025

Here's Why We're Not Too Worried About Delcath Systems' (NASDAQ:DCTH) Cash Burn Situation - Yahoo Finance

Mar 07, 2025